Suppression of experimental autoimmune myasthenia gravis by combination therapy: Pentoxifylline as a steroid-sparing agent-Reference-Cited by-同舟云学术

Suppression of experimental autoimmune myasthenia gravis by combination therapy: Pentoxifylline as a steroid-sparing agent

Published:2008-09 Issue: Volume:201-202 Page:128-135
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Menon Renuka T.R.,Feferman Tali,Aricha Revital,Souroujon Miriam C.,Fuchs Sara

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference39 articles.

1. The anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline in the rat;Abdel-Salam;Pharmacol. Res.,2003

2. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells;Ahlstrom;Biochem. Pharmacol.,2005

3. Immunosuppressive drugs: the first 50 years and a glance forward;Allison;Immunopharmacology,2000

4. Evidence that glucocorticosteroid-mediated immunosuppressive effects do not involve altering second messenger function;Almawi;Transplantation,1991

5. Phosphodiesterase inhibitor pentoxifylline: an antiinflammatory/immunomodulatory drug potentially useful in some rheumatic diseases;Anaya;J. Rheumatol.,1995

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the causal relationship between inflammatory cytokines and myasthenia gravis: A bidirectional and two-sample Mendelian randomization study;2024-01-05

2. A Recombinant Acetylcholine Receptor α1 Subunit Extracellular Domain Is a Promising New Drug Candidate for Treatment Of Myasthenia Gravis;Frontiers in Immunology;2022-06-03

3. Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors — Recommendations for methods and experimental designs;Experimental Neurology;2015-08

4. Experimental Autoimmune Myasthenia Gravis (EAMG): From immunochemical characterization to therapeutic approaches;Journal of Autoimmunity;2014-11

5. Influence of dipyridamole and its combination with NO donor or NO synthase inhibitor on adjuvant arthritis;International Immunopharmacology;2010-11